The programmed cell death of macrophages, endothelial cells, and tubular epithelial cells in sepsis-AKI

C Li, W Wang, S Xie, W Ma, Q Fan, Y Chen, Y He… - Frontiers in …, 2021 - frontiersin.org
Sepsis is a systemic inflammatory response syndrome caused by infection, following with
acute injury to multiple organs. Sepsis-induced acute kidney injury (AKI) is currently …

Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy

S Balagholi, R Dabbaghi, P Eshghi, SA Mousavi… - … and Apheresis Science, 2020 - Elsevier
Therapeutic plasmapheresis (TP) is the process of the separation and removal of plasma
from other blood components and is considered as an adjunctive treatment strategy to the …

The role of HMGB1 in COVID‐19‐induced cytokine storm and its potential therapeutic targets: A review

S Wulandari, Hartono, T Wibawa - Immunology, 2023 - Wiley Online Library
Hyperinflammation characterized by elevated proinflammatory cytokines known as 'cytokine
storms' is the major cause of high severity and mortality seen in COVID‐19 patients. The …

Discrimination of COVID‐19 from inflammation‐induced cytokine storm syndromes using disease‐related blood biomarkers

C Kessel, R Vollenberg… - Arthritis & …, 2021 - Wiley Online Library
Objective Infection with the novel coronavirus SARS–CoV‐2 triggers severe illness with high
mortality in a subgroup of patients. Such a critical course of COVID‐19 is thought to be …

Pathogenesis and treatment of refractory disease courses in systemic juvenile idiopathic arthritis: refractory arthritis, recurrent macrophage activation syndrome and …

R Erkens, Y Esteban, C Towe… - Rheumatic Disease …, 2021 - rheumatic.theclinics.com
Systemic juvenile idiopathic arthritis (sJIA) is generally seen as the most severe category of
JIA. These categories are distinct in their pathobiology, disease course and specific …

[HTML][HTML] Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment

PC Lara, J Burgos, D Macias - Clinical and translational radiation oncology, 2020 - Elsevier
The COVID-19 pandemia is affecting people worldwide. Most of the patients suffered of a
respiratory disease that will progress to an acute respiratory distress syndrome (ARDS) …

[HTML][HTML] Hemostatic alterations in COVID-19

F Peyvandi, A Artoni, C Novembrino, S Aliberti… - …, 2021 - ncbi.nlm.nih.gov
Coronavirus disease 2019 (COVID-19) is caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), 1, 2 that, first identified in China, has spread globally. A …

Arterial and venous thrombosis complicated in COVID-19: a retrospective single center analysis in Japan

S Oba, T Hosoya, M Amamiya, T Mitsumura… - Frontiers in …, 2021 - frontiersin.org
Background: Thrombosis is a characteristic complication in coronavirus disease 2019
(COVID-19). Since coagulopathy has been observed over the entire clinical course …

Interleukin-18 binding protein in immune regulation and autoimmune diseases

SY Park, Y Hisham, HM Shin, SC Yeom, S Kim - Biomedicines, 2022 - mdpi.com
Natural soluble antagonist and decoy receptor on the surface of the cell membrane are
evolving as crucial immune system regulators as these molecules are capable of …

[HTML][HTML] Multifunctional nanoprobes for macrophage imaging

H Deng, L Xu, J Ju, X Mo, G Ge, X Zhu - Biomaterials, 2022 - Elsevier
Imaging and tracking macrophage behaviors in vivo are essential to reveal its biological
function and fate in various diseases. Small molecular probes suffer from poor macrophage …